Magnetic resonance fingerprinting for preoperative differentiation between gonadotroph and non-gonadotroph pituitary macroadenomas.

Yan BaiYu ShenRushi ChenXianchang ZhangMathias NittkaGregor KoerzdoerferQiyong GongMeiyun Wang

Published in: European radiology (2021)

• Somatostatin receptor type 3 is the most abundant receptor subtype in gonadotroph pituitary adenomas. • Magnetic resonance fingerprinting may help to preoperatively differentiate between gonadotroph and non-gonadotroph pituitary macroadenomas. • Magnetic resonance fingerprinting shows potential for guiding the treatment of pituitary macroadenomas.

Keyphrases

magnetic resonance
growth hormone
contrast enhanced
magnetic resonance imaging
binding protein
combination therapy